SPOREGEN LIMITED Information

View Top Employees from SPOREGEN LIMITED

SPOREGEN LIMITED is a biotechnology company based at The London BioScience Innovation Centre (LBIC) in London. SPOREGEN is focused on four areas. 1. Clostridium difficile: we have developed a unique prophylactic and therapeutic approach for C. difficile infection. 2. Probiotics: we identify and develop Bacillus, heat stable, spore probiotic formulations. This includes progression to GRAS status and a number of these have now been licenced including HU58 and HU36. 3. Prophylactic approaches to COVID-19 including SPOR-COV, a unique mucosal immune modulator, and SPORCOVAX, a mucosal vaccine. 4. Contracts: focusing primarily on in vivo evaluations of C. difficile interventions.

Website	http://www.sporegen.com/
Employees	4 (2 on RocketReach)
Founded	2012
Address	2 Royal College Street, London, England NW1 0NH, GB
Phone	+44 1784 443760
Technologies	JavaScript , HTML , Google Analytics +6 more (view full list)
Industry	Biotechnology Research, Business Services General, Laboratory Services (Healthcare), Business Services
Keywords	Biotechnology, Probiotics, Infectious Disease, Drug Development, Anti-Infective, Microbial Therapeutics, Microbiome, Gut Health, Pharmaceutical, Biologics, Biotechnology Research, Scientific Research, Life Sciences, Health Technology, Clinical Trials
Competitors	Zymergen, Inc., Amyris, Geno, Synlogic, Moderna Therapeutics, Arzeda, TERSUS ENERGY LIMITED, Novozymes, Bolt Threads, CARBIO +25 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies